Determining the cost‐effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions

Abstract

Endoscopic surveillance of gastric premalignancies can be a cost-effective strategy for GC prevention. Its implementation requires careful assessment on factors influencing the actual cost-effectiveness.